Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First Line Therapy With Methotrexate (MTX) and Second Line Therapy With Fludarabine of Patients With T-Cell Large Granular Lymphocyte Leukemia (T-LGL)

NCT00278265 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00278265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00278265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First Line Therapy With Methotrexate (MTX) and Second Line Therapy With Fludarabine of Patients With T-Cell Large Granular Lymphocyte Leukemia (T-LGL)
Lead sponsor
German CLL Study Group
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2005
Completion date
December 31, 2009
Enrollment
12 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

t-cell large granular lymphocytic leukemia